{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:10:51Z","timestamp":1792699851099,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Alzheimer\u2019s disease (AD) is considered to have a large genetic component. Our knowledge of this component has progressed over the last 10 years, thanks notably to the advent of genome-wide association studies and the establishment of large consortia that make it possible to analyze hundreds of thousands of cases and controls. The characterization of dozens of chromosomal regions associated with the risk of developing AD and (in some loci) the causal genes responsible for the observed disease signal has confirmed the involvement of major pathophysiological pathways (such as amyloid precursor protein metabolism) and opened up new perspectives (such as the central role of microglia and inflammation). Furthermore, large-scale sequencing projects are starting to reveal the major impact of rare variants \u2013 even in genes like\n                    <jats:italic>APOE<\/jats:italic>\n                    \u2013 on the AD risk. This increasingly comprehensive knowledge is now being disseminated through translational research; in particular, the development of genetic risk\/polygenic risk scores is helping to identify the subpopulations more at risk or less at risk of developing AD. Although it is difficult to assess the efforts still needed to comprehensively characterize the genetic component of AD, several lines of research can be improved or initiated. Ultimately, genetics (in combination with other biomarkers) might help to redefine the boundaries and relationships between various neurodegenerative diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41380-023-02076-1","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:03:02Z","timestamp":1683000182000},"page":"2716-2727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Step by step: towards a better understanding of the genetic architecture of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-7817","authenticated-orcid":false,"given":"Jean-Charles","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4991-763X","authenticated-orcid":false,"given":"Alfredo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Grenier-Boley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-7874","authenticated-orcid":false,"given":"C\u00e9line","family":"Bellenguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"2076_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349:704\u20136.","journal-title":"Nature."},{"key":"2076_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375:754\u201360.","journal-title":"Nature."},{"key":"2076_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.7638622","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus. Science. 1995;269:973\u20137.","journal-title":"Science."},{"key":"2076_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"J Hardy","year":"1992","unstructured":"Hardy J, Higgins G. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science."},{"key":"2076_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18:794\u20139.","journal-title":"Nat Neurosci"},{"key":"2076_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. 2016;8:595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"2076_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2022;23:53\u201366.","journal-title":"Nat Rev Neurosci"},{"key":"2076_CR8","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:1977\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2076_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"EH Corder","year":"1994","unstructured":"Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7:180\u20134.","journal-title":"Nat Genet"},{"key":"2076_CR10","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.psyneuen.2007.05.015","volume":"32","author":"J-C Lambert","year":"2007","unstructured":"Lambert J-C, Amouyel P. Genetic heterogeneity of Alzheimer\u2019s disease: complexity and advances. Psychoneuroendocrinology. 2007;32:S62\u201370.","journal-title":"Psychoneuroendocrinology."},{"key":"2076_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17\u201323.","journal-title":"Nat Genet"},{"key":"2076_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archneur.57.2.210","volume":"57","author":"LA Farrer","year":"2000","unstructured":"Farrer LA, Sherbatich T, Keryanov SA, Korovaitseva GI, Rogaeva EA, Petruk S, et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol. 2000;57:210\u20134.","journal-title":"Arch Neurol"},{"key":"2076_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39:168\u201377.","journal-title":"Nat Genet"},{"key":"2076_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1094\u20139.","journal-title":"Nat Genet"},{"key":"2076_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41:1088\u201393.","journal-title":"Nat Genet"},{"key":"2076_CR16","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S. Genome-wide analysis of genetic loci associated with Alzheimer Disease. JAMA. 2010;303:1832.","journal-title":"JAMA."},{"key":"2076_CR17","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45:1452\u20138.","journal-title":"Nat Genet"},{"key":"2076_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43:429\u201335.","journal-title":"Nat Genet"},{"key":"2076_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN, Buros J, et al. Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet. 2011;43:436\u201341.","journal-title":"Nat Genet"},{"key":"2076_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"2076_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"2076_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12:3417.","journal-title":"Nat Commun"},{"key":"2076_CR23","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet. 2021;53:1276\u201382.","journal-title":"Nat Genet"},{"key":"2076_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/ng.3766","volume":"49","author":"JZ Liu","year":"2017","unstructured":"Liu JZ, Erlich Y, Pickrell JK. Case-control association mapping by proxy using family history of disease. Nat Genet. 2017;49:325\u201331.","journal-title":"Nat Genet"},{"key":"2076_CR25","doi-asserted-by":"crossref","unstructured":"Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, et al. GWAS on family history of Alzheimer\u2019s disease. Transl Psychiatry. 2018;8:99.","DOI":"10.1038\/s41398-018-0150-6"},{"key":"2076_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41588-020-00776-w","volume":"53","author":"J Schwartzentruber","year":"2021","unstructured":"Schwartzentruber J, Cooper S, Liu JZ, Barrio-Hernandez I, Bello E, Kumasaka N, et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer\u2019s disease risk genes. Nat Genet. 2021;53:392\u2013402.","journal-title":"Nat Genet"},{"key":"2076_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54:412\u201336.","journal-title":"Nat Genet"},{"key":"2076_CR28","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/archneurol.2011.646","volume":"68","author":"MW Logue","year":"2011","unstructured":"Logue MW, Schu M, Vardarajan BN, Buros J, Green RC, Go RCP, et al. A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011;68:1569\u201379.","journal-title":"Arch Neurol"},{"key":"2076_CR29","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang L-S, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E \u03f54,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309:1483\u201392.","journal-title":"JAMA."},{"key":"2076_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","volume":"78","author":"BW Kunkle","year":"2021","unstructured":"Kunkle BW, Schmidt M, Klein H-U, Naj AC, Hamilton-Nelson KL, Larson EB, et al. Novel Alzheimer Disease risk loci and pathways in African American individuals using the African genome resources panel: a meta-analysis. JAMA Neurol. 2021;78:102\u201313.","journal-title":"JAMA Neurol"},{"key":"2076_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13195-021-00866-9","volume":"13","author":"ARVR Horimoto","year":"2021","unstructured":"Horimoto ARVR, Xue D, Thornton TA, Blue EE. Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer\u2019s disease in Caribbean Hispanics. Alzheimers Res Ther. 2021;13:122.","journal-title":"Alzheimers Res Ther"},{"key":"2076_CR32","doi-asserted-by":"publisher","first-page":"115.e1","DOI":"10.1016\/j.neurobiolaging.2021.02.019","volume":"104","author":"F Rajabli","year":"2021","unstructured":"Rajabli F, Feliciano-Astacio BE, Cukier HN, Wang L, Griswold AJ, Hamilton-Nelson KL, et al. Linkage of Alzheimer disease families with Puerto Rican ancestry identifies a chromosome 9 locus. Neurobiol Aging. 2021;104:115.e1\u2013115.e7.","journal-title":"Neurobiol Aging"},{"key":"2076_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0394-9","volume":"9","author":"MC Dalmasso","year":"2019","unstructured":"Dalmasso MC, Brusco LI, Olivar N, Muchnik C, Hanses C, Milz E, et al. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer\u2019s disease. Transl Psychiatry. 2019;9:55.","journal-title":"Transl Psychiatry"},{"key":"2076_CR34","doi-asserted-by":"publisher","first-page":"632314","DOI":"10.3389\/fmolb.2021.632314","volume":"8","author":"GC Kretzschmar","year":"2021","unstructured":"Kretzschmar GC, Alencar NM, da Silva SSL, Sulzbach CD, Meissner CG, Petzl-Erler ML, et al. GWAS-top polymorphisms associated with late-onset Alzheimer Disease in Brazil: pointing out possible new culprits among non-coding RNAs. Front Mol Biosci. 2021;8:632314.","journal-title":"Front Mol Biosci"},{"key":"2076_CR35","doi-asserted-by":"publisher","first-page":"298.e11","DOI":"10.1016\/j.neurobiolaging.2020.10.003","volume":"101","author":"MV Marca-Ysabel","year":"2021","unstructured":"Marca-Ysabel MV, Rajabli F, Cornejo-Olivas M, Whitehead PG, Hofmann NK, Illanes Manrique MZ, et al. Dissecting the role of Amerindian genetic ancestry and the ApoE \u03b54 allele on Alzheimer disease in an admixed Peruvian population. Neurobiol Aging. 2021;101:298.e11\u2013298.e15.","journal-title":"Neurobiol Aging"},{"key":"2076_CR36","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3233\/JAD-210145","volume":"82","author":"S Kang","year":"2021","unstructured":"Kang S, Gim J, Lee J, Gunasekaran TI, Choi KY, Lee JJ, et al. Potential novel genes for late-onset Alzheimer\u2019s Disease in East-Asian descent identified by APOE-stratified genome-wide association study. J Alzheimers Dis JAD. 2021;82:1451\u201360.","journal-title":"J Alzheimers Dis JAD"},{"key":"2076_CR37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/brain\/awaa364","volume":"144","author":"L Jia","year":"2021","unstructured":"Jia L, Li F, Wei C, Zhu M, Qu Q, Qin W, et al. Prediction of Alzheimer\u2019s disease using multi-variants from a Chinese genome-wide association study. Brain J Neurol. 2021;144:924\u201337.","journal-title":"Brain J Neurol"},{"key":"2076_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01272-3","volume":"11","author":"D Shigemizu","year":"2021","unstructured":"Shigemizu D, Mitsumori R, Akiyama S, Miyashita A, Morizono T, Higaki S, et al. Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer\u2019s disease risk. Transl Psychiatry. 2021;11:151.","journal-title":"Transl Psychiatry"},{"key":"2076_CR39","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49:1373\u201384.","journal-title":"Nat Genet"},{"key":"2076_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/mp.2012.15","volume":"17","author":"C Pottier","year":"2012","unstructured":"Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatry. 2012;17:875\u20139.","journal-title":"Mol Psychiatry"},{"key":"2076_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"2076_CR42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"2076_CR43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng.3246","volume":"47","author":"S Steinberg","year":"2015","unstructured":"Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H, et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer\u2019s disease. Nat Genet. 2015;47:445\u20137.","journal-title":"Nat Genet"},{"key":"2076_CR44","doi-asserted-by":"publisher","first-page":"220.e1","DOI":"10.1016\/j.neurobiolaging.2017.07.001","volume":"59","author":"C Bellenguez","year":"2017","unstructured":"Bellenguez C, Charbonnier C, Grenier-Boley B, Quenez O, Le Guennec K, Nicolas G, et al. Contribution to Alzheimer\u2019s disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls. Neurobiol Aging. 2017;59:220.e1\u2013220.e9.","journal-title":"Neurobiol Aging"},{"key":"2076_CR45","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41380-018-0112-7","volume":"25","author":"JC Bis","year":"2020","unstructured":"Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, et al. Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2020;25:1859\u201375.","journal-title":"Mol Psychiatry"},{"key":"2076_CR46","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.22.20159251","author":"H Holstege","year":"2020","unstructured":"Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, et al. Exome sequencing identifies novel AD-associated genes. MedRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.07.22.20159251.","journal-title":"MedRxiv"},{"key":"2076_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, Combarros O, et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16:903\u20137.","journal-title":"Mol Psychiatry"},{"key":"2076_CR48","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.jalz.2019.05.011","volume":"15","author":"AJ Huq","year":"2019","unstructured":"Huq AJ, Fransquet P, Laws SM, Ryan J, Sebra R, Masters CL, et al. Genetic resilience to Alzheimer\u2019s disease in APOE \u03b54 homozygotes: a systematic review. Alzheimers Dement J Alzheimers Assoc. 2019;15:1612\u201323.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR49","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaneurol.2020.0414","volume":"77","author":"ME Belloy","year":"2020","unstructured":"Belloy ME, Napolioni V, Han SS, Le Guen Y, Greicius MD. Alzheimer\u2019s Disease Neuroimaging Initiative. Association of Klotho-VS heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol. 2020;77:849\u201362.","journal-title":"JAMA Neurol"},{"key":"2076_CR50","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2019.1456","volume":"76","author":"Y Ma","year":"2019","unstructured":"Ma Y, Jun GR, Zhang X, Chung J, Naj AC, Chen Y, et al. Analysis of whole-exome sequencing data for Alzheimer disease stratified by APOE genotype. JAMA Neurol. 2019;76:1099\u2013108.","journal-title":"JAMA Neurol"},{"key":"2076_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S1474-4422(18)30053-X","volume":"17","author":"SJ van der Lee","year":"2018","unstructured":"van der Lee SJ, Wolters FJ, Ikram MK, Hofman A, Ikram MA, Amin N, et al. The effect of APOE and other common genetic variants on the onset of Alzheimer\u2019s disease and dementia: a community-based cohort study. Lancet Neurol. 2018;17:434\u201344.","journal-title":"Lancet Neurol"},{"key":"2076_CR52","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1093\/eurheartj\/ehaa695","volume":"41","author":"I Juul Rasmussen","year":"2020","unstructured":"Juul Rasmussen I, Rasmussen KL, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Frikke-Schmidt R. Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention. Eur Heart J. 2020;41:4024\u201333.","journal-title":"Eur Heart J"},{"key":"2076_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ng0198-69","volume":"18","author":"MJ Bullido","year":"1998","unstructured":"Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garc\u00eda MA, Aldudo J, et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer\u2019s dementia. Nat Genet. 1998;18:69\u201371.","journal-title":"Nat Genet"},{"key":"2076_CR54","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/hmg\/7.9.1511","volume":"7","author":"JC Lambert","year":"1998","unstructured":"Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, et al. Pronounced impact of Th1\/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer\u2019s disease. Hum Mol Genet. 1998;7:1511\u20136.","journal-title":"Hum Mol Genet"},{"key":"2076_CR55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1212\/WNL.59.1.59","volume":"59","author":"J-C Lambert","year":"2002","unstructured":"Lambert J-C, Araria-Goumidi L, Myllykangas L, Ellis C, Wang JC, Bullido MJ, et al. Contribution of APOE promoter polymorphisms to Alzheimer\u2019s disease risk. Neurology. 2002;59:59\u201366.","journal-title":"Neurology."},{"key":"2076_CR56","doi-asserted-by":"publisher","first-page":"e1007791","DOI":"10.1371\/journal.pgen.1007791","volume":"14","author":"F Rajabli","year":"2018","unstructured":"Rajabli F, Feliciano BE, Celis K, Hamilton-Nelson KL, Whitehead PL, Adams LD, et al. Ancestral origin of ApoE \u03b54 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 2018;14:e1007791.","journal-title":"PLoS Genet"},{"key":"2076_CR57","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1212\/NXG.0000000000000404","volume":"6","author":"PL Bussies","year":"2020","unstructured":"Bussies PL, Rajabli F, Griswold A, Dorfsman DA, Whitehead P, Adams LD, et al. Use of local genetic ancestry to assess TOMM40-523\u2019 and risk for Alzheimer disease. Neurol Genet. 2020;6:e404.","journal-title":"Neurol Genet"},{"key":"2076_CR58","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/alz.12534","volume":"18","author":"K Nuytemans","year":"2022","unstructured":"Nuytemans K, Lipkin Vasquez M, Wang L, Van Booven D, Griswold AJ, Rajabli F, et al. Identifying differential regulatory control of APOE \u025b4 on African versus European haplotypes as potential therapeutic targets. Alzheimers Dement J Alzheimers Assoc. 2022;18:1930\u201342.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR59","doi-asserted-by":"publisher","first-page":"e1009977","DOI":"10.1371\/journal.pgen.1009977","volume":"18","author":"F Rajabli","year":"2022","unstructured":"Rajabli F, Beecham GW, Hendrie HC, Baiyewu O, Ogunniyi A, Gao S, et al. A locus at 19q13.31 significantly reduces the ApoE \u03b54 risk for Alzheimer\u2019s Disease in African Ancestry. PLoS Genet. 2022;18:e1009977.","journal-title":"PLoS Genet"},{"key":"2076_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1326-9-11","volume":"9","author":"CW Medway","year":"2014","unstructured":"Medway CW, Abdul-Hay S, Mims T, Ma L, Bisceglio G, Zou F, et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:11.","journal-title":"Mol Neurodegener"},{"key":"2076_CR61","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen Y, Belloy ME, Grenier-Boley B, de Rojas I, Castillo-Morales A, Jansen I, et al. Association of rare APOE missense variants V236E and R251G with risk of Alzheimer disease. JAMA Neurol. 2022;79:652\u201363.","journal-title":"JAMA Neurol"},{"key":"2076_CR62","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/alz.12165","volume":"16","author":"KL Rasmussen","year":"2020","unstructured":"Rasmussen KL, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. APOE and dementia - resequencing and genotyping in 105,597 individuals. Alzheimers Dement J Alzheimers Assoc. 2020;16:1624\u201337.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR63","doi-asserted-by":"publisher","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"C-C Liu","year":"2021","unstructured":"Liu C-C, Murray ME, Li X, Zhao N, Wang N, Heckman MG, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13:eabc9375.","journal-title":"Sci Transl Med"},{"key":"2076_CR64","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u20133.","journal-title":"Nat Med"},{"key":"2076_CR65","doi-asserted-by":"publisher","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease. PloS One. 2010;5:e13950.","journal-title":"PloS One"},{"key":"2076_CR66","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3233\/JAD-2010-100018","volume":"20","author":"J-C Lambert","year":"2010","unstructured":"Lambert J-C, Grenier-Boley B, Chouraki V, Heath S, Zelenika D, Fievet N, et al. Implication of the immune system in Alzheimer\u2019s disease: evidence from genome-wide pathway analysis. J Alzheimers Dis JAD. 2010;20:1107\u201318.","journal-title":"J Alzheimers Dis JAD"},{"key":"2076_CR67","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/s41588-021-00945-5","volume":"53","author":"E Mountjoy","year":"2021","unstructured":"Mountjoy E, Schmidt EM, Carmona M, Schwartzentruber J, Peat G, Miranda A, et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci. Nat Genet. 2021;53:1527\u201333.","journal-title":"Nat Genet"},{"key":"2076_CR68","doi-asserted-by":"publisher","first-page":"e1004722","DOI":"10.1371\/journal.pgen.1004722","volume":"10","author":"G Kichaev","year":"2014","unstructured":"Kichaev G, Yang W-Y, Lindstrom S, Hormozdiari F, Eskin E, Price AL, et al. Integrating functional data to prioritize causal variants in statistical fine-mapping studies. PLoS Genet. 2014;10:e1004722.","journal-title":"PLoS Genet"},{"key":"2076_CR69","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1093\/hmg\/dds098","volume":"21","author":"C Wallace","year":"2012","unstructured":"Wallace C, Rotival M, Cooper JD, Rice CM, Yang JHM, McNeill M, et al. Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes. Hum Mol Genet. 2012;21:2815\u201324.","journal-title":"Hum Mol Genet"},{"key":"2076_CR70","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"2076_CR71","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41588-019-0385-z","volume":"51","author":"M Wainberg","year":"2019","unstructured":"Wainberg M, Sinnott-Armstrong N, Mancuso N, Barbeira AN, Knowles DA, Golan D, et al. Opportunities and challenges for transcriptome-wide association studies. Nat Genet. 2019;51:592\u20139.","journal-title":"Nat Genet"},{"key":"2076_CR72","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17:1156\u201363.","journal-title":"Nat Neurosci"},{"key":"2076_CR73","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17:1164\u201370.","journal-title":"Nat Neurosci"},{"key":"2076_CR74","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet. 2021;53:143\u20136.","journal-title":"Nat Genet"},{"key":"2076_CR75","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","volume":"102","author":"MD Gallagher","year":"2018","unstructured":"Gallagher MD, Chen-Plotkin AS. The post-GWAS era: from association to function. Am J Hum Genet. 2018;102:717\u201330.","journal-title":"Am J Hum Genet"},{"key":"2076_CR76","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1073\/pnas.1315110110","volume":"110","author":"Y Tian","year":"2013","unstructured":"Tian Y, Chang JC, Fan EY, Flajolet M, Greengard P. Adaptor complex AP2\/PICALM, through interaction with LC3, targets Alzheimer\u2019s APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci USA. 2013;110:17071\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2076_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15252\/embr.201642738","volume":"18","author":"F Ubelmann","year":"2017","unstructured":"Ubelmann F, Burrinha T, Salavessa L, Gomes R, Ferreira C, Moreno N, et al. Bin1 and CD2AP polarise the endocytic generation of beta-amyloid. EMBO Rep. 2017;18:102\u201322.","journal-title":"EMBO Rep"},{"key":"2076_CR78","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","volume":"36","author":"N Sakae","year":"2016","unstructured":"Sakae N, Liu C-C, Shinohara M, Frisch-Daiello J, Ma L, Yamazaki Y, et al. ABCA7 deficiency accelerates amyloid-\u03b2 generation and Alzheimer\u2019s neuronal pathology. J Neurosci. 2016;36:3848\u201359.","journal-title":"J Neurosci"},{"key":"2076_CR79","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jalz.2017.01.016","volume":"13","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Russell JC, Carr DT, Burgess JD, Allen M, Serie DJ, et al. Systems biology approach to late-onset Alzheimer\u2019s disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments. Alzheimers Dement J Alzheimers Assoc. 2017;13:1133\u201342.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR80","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00401-016-1652-z","volume":"133","author":"J Chapuis","year":"2017","unstructured":"Chapuis J, Flaig A, Grenier-Boley B, Eysert F, Pottiez V, Deloison G, et al. Genome-wide, high-content siRNA screening identifies the Alzheimer\u2019s genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathol. 2017;133:955\u201366.","journal-title":"Acta Neuropathol"},{"key":"2076_CR81","doi-asserted-by":"publisher","first-page":"e0115369","DOI":"10.1371\/journal.pone.0115369","volume":"10","author":"LM Camargo","year":"2015","unstructured":"Camargo LM, Zhang XD, Loerch P, Caceres RM, Marine SD, Uva P, et al. Pathway-based analysis of genome-wide siRNA screens reveals the regulatory landscape of APP processing. PloS One. 2015;10:e0115369.","journal-title":"PloS One"},{"key":"2076_CR82","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1073\/pnas.1201632109","volume":"109","author":"J Bali","year":"2012","unstructured":"Bali J, Gheinani AH, Zurbriggen S, Rajendran L. Role of genes linked to sporadic Alzheimer\u2019s disease risk in the production of \u03b2-amyloid peptides. Proc Natl Acad Sci USA. 2012;109:15307\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2076_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-019-02004-0","volume":"138","author":"P Dourlen","year":"2019","unstructured":"Dourlen P, Kilinc D, Malmanche N, Chapuis J, Lambert J-C. The new genetic landscape of Alzheimer\u2019s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? Acta Neuropathol. 2019;138:221\u201336.","journal-title":"Acta Neuropathol"},{"key":"2076_CR84","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/hmg\/ddt478","volume":"23","author":"JM Shulman","year":"2014","unstructured":"Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, et al. Functional screening in Drosophila identifies Alzheimer\u2019s disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet. 2014;23:870\u20137.","journal-title":"Hum Mol Genet"},{"key":"2076_CR85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ajhg.2011.01.006","volume":"88","author":"JM Shulman","year":"2011","unstructured":"Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, et al. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011;88:232\u20138.","journal-title":"Am J Hum Genet"},{"key":"2076_CR86","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/mp.2016.59","volume":"22","author":"P Dourlen","year":"2017","unstructured":"Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Mol Psychiatry. 2017;22:874\u201383.","journal-title":"Mol Psychiatry"},{"key":"2076_CR87","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00401-020-02125-x","volume":"139","author":"K Ando","year":"2020","unstructured":"Ando K, De Decker R, Vergara C, Yilmaz Z, Mansour S, Suain V, et al. Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathol. 2020;139:773\u201389.","journal-title":"Acta Neuropathol"},{"key":"2076_CR88","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry. 2013;18:1225\u201334.","journal-title":"Mol Psychiatry"},{"key":"2076_CR89","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00401-019-02017-9","volume":"138","author":"M Sartori","year":"2019","unstructured":"Sartori M, Mendes T, Desai S, Lasorsa A, Herledan A, Malmanche N, et al. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylation. Acta Neuropathol. 2019;138:631\u201352.","journal-title":"Acta Neuropathol"},{"key":"2076_CR90","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40478-015-0237-8","volume":"3","author":"Y Sottejeau","year":"2015","unstructured":"Sottejeau Y, Bretteville A, Cantrelle F-X, Malmanche N, Demiaute F, Mendes T, et al. Tau phosphorylation regulates the interaction between BIN1\u2019s SH3 domain and Tau\u2019s proline-rich domain. Acta Neuropathol Commun. 2015;3:58.","journal-title":"Acta Neuropathol Commun"},{"key":"2076_CR91","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genet. 2014;10:e1004606.","journal-title":"PLoS Genet"},{"key":"2076_CR92","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021;53:294\u2013303.","journal-title":"Nat Genet"},{"key":"2076_CR93","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-022-02454-z","volume":"144","author":"IE Jansen","year":"2022","unstructured":"Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, et al. Genome-wide meta-analysis for Alzheimer\u2019s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 2022;144:821\u201342.","journal-title":"Acta Neuropathol"},{"key":"2076_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09564-5","volume":"10","author":"N Franzmeier","year":"2019","unstructured":"Franzmeier N, Rubinski A, Neitzel J, Ewers M. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun. 2019;10:1766.","journal-title":"Nat Commun"},{"key":"2076_CR95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12371","volume":"18","author":"N Franzmeier","year":"2022","unstructured":"Franzmeier N, Ossenkoppele R, Brendel M, Rubinski A, Smith R, Kumar A, et al. The BIN1 rs744373 Alzheimer\u2019s disease risk SNP is associated with faster A\u03b2-associated tau accumulation and cognitive decline. Alzheimers Dement J Alzheimers Assoc. 2022;18:103\u201315.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR96","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott A, Holtman IR, Coufal NG, Schlachetzki JCM, Yu M, Hu R, et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science. 2019;366:1134\u20139.","journal-title":"Science."},{"key":"2076_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, et al. Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun. 2021;12:1610.","journal-title":"Nat Commun"},{"key":"2076_CR98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","volume":"54","author":"K Lopes","year":"2022","unstructured":"Lopes K, de P, Snijders GJL, Humphrey J, Allan A, Sneeboer MAM, et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat Genet. 2022;54:4\u201317.","journal-title":"Nat Genet"},{"key":"2076_CR99","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1084\/jem.20151948","volume":"213","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, et al. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med. 2016;213:667\u201375.","journal-title":"J Exp Med"},{"key":"2076_CR100","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron."},{"key":"2076_CR101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s40478-021-01263-x","volume":"9","author":"P Joshi","year":"2021","unstructured":"Joshi P, Riffel F, Kumar S, Villacampa N, Theil S, Parhizkar S, et al. TREM2 modulates differential deposition of modified and non-modified A\u03b2 species in extracellular plaques and intraneuronal deposits. Acta Neuropathol Commun. 2021;9:168.","journal-title":"Acta Neuropathol Commun"},{"key":"2076_CR102","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.immuni.2018.04.016","volume":"48","author":"F Filipello","year":"2018","unstructured":"Filipello F, Morini R, Corradini I, Zerbi V, Canzi A, Michalski B, et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity. Immunity. 2018;48:979\u2013.e8.","journal-title":"Immunity."},{"key":"2076_CR103","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.conb.2015.12.004","volume":"36","author":"S Hong","year":"2016","unstructured":"Hong S, Dissing-Olesen L, Stevens B. New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol. 2016;36:128\u201334.","journal-title":"Curr Opin Neurobiol"},{"key":"2076_CR104","doi-asserted-by":"publisher","first-page":"e10606","DOI":"10.15252\/emmm.201910606","volume":"12","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E, et al. Novel Alzheimer risk genes determine the microglia response to amyloid-\u03b2 but not to TAU pathology. EMBO Mol Med. 2020;12:e10606.","journal-title":"EMBO Mol Med"},{"key":"2076_CR105","doi-asserted-by":"publisher","first-page":"e20210542","DOI":"10.1084\/jem.20210542","volume":"218","author":"M Gratuze","year":"2021","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, et al. Activated microglia mitigate A\u03b2-associated tau seeding and spreading. J Exp Med. 2021;218:e20210542.","journal-title":"J Exp Med"},{"key":"2076_CR106","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Pr\u00f3chnicki T, van der Lee SJ, Madrid-M\u00e1rquez L, Wagner-Thelen H, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139:1025\u201344.","journal-title":"Acta Neuropathol"},{"key":"2076_CR107","doi-asserted-by":"publisher","first-page":"105398","DOI":"10.1016\/j.nbd.2021.105398","volume":"155","author":"A Vautheny","year":"2021","unstructured":"Vautheny A, Duwat C, Aur\u00e9gan G, Jos\u00e9phine C, H\u00e9rard A-S, Jan C, et al. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency. Neurobiol Dis. 2021;155:105398.","journal-title":"Neurobiol Dis"},{"key":"2076_CR108","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of Alzheimer\u2019s disease. Cell. 2016;164:603\u201315.","journal-title":"Cell"},{"key":"2076_CR109","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ng.3285","volume":"47","author":"TJC Polderman","year":"2015","unstructured":"Polderman TJC, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015;47:702\u20139.","journal-title":"Nat Genet"},{"key":"2076_CR110","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3941","volume":"49","author":"J Yang","year":"2017","unstructured":"Yang J, Zeng J, Goddard ME, Wray NR, Visscher PM. Concepts, estimation and interpretation of SNP-based heritability. Nat Genet. 2017;49:1304\u201310.","journal-title":"Nat Genet"},{"key":"2076_CR111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00439-019-02034-4","volume":"139","author":"E G\u00e9nin","year":"2020","unstructured":"G\u00e9nin E. Missing heritability of complex diseases: case solved? Hum Genet. 2020;139:103\u201313.","journal-title":"Hum Genet"},{"key":"2076_CR112","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1073\/pnas.1119675109","volume":"109","author":"O Zuk","year":"2012","unstructured":"Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci. 2012;109:1193\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"2076_CR113","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Loh PR, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291\u20135.","journal-title":"Nat Genet"},{"key":"2076_CR114","doi-asserted-by":"publisher","first-page":"E5272","DOI":"10.1073\/pnas.1419064111","volume":"111","author":"D Golan","year":"2014","unstructured":"Golan D, Lander ES, Rosset S. Measuring missing heritability: Inferring the contribution of common variants. Proc Natl Acad Sci. 2014;111:E5272\u2013E5281.","journal-title":"Proc Natl Acad Sci"},{"key":"2076_CR115","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ajhg.2018.06.002","volume":"103","author":"O Weissbrod","year":"2018","unstructured":"Weissbrod O, Flint J, Rosset S. Estimating SNP-based heritability and genetic correlation in case-control studies directly and with summary statistics. Am J Hum Genet. 2018;103:89\u201399.","journal-title":"Am J Hum Genet"},{"key":"2076_CR116","doi-asserted-by":"publisher","first-page":"214.e7","DOI":"10.1016\/j.neurobiolaging.2016.07.018","volume":"49","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price V, Shoai M, Pither R, Williams J, Hardy J. Polygenic score prediction captures nearly all common genetic risk for Alzheimer\u2019s disease. Neurobiol Aging. 2017;49:214.e7\u2013214.e11.","journal-title":"Neurobiol Aging"},{"key":"2076_CR117","doi-asserted-by":"publisher","first-page":"e1010208","DOI":"10.1371\/journal.pgen.1010208","volume":"18","author":"J Fuente","year":"2022","unstructured":"Fuente J, de la, Grotzinger AD, Marioni RE, Nivard MG, Tucker-Drob EM. Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer\u2019s disease outside of the APOE region. PLOS Genet. 2022;18:e1010208.","journal-title":"PLOS Genet"},{"key":"2076_CR118","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane HK, Bulik-Sullivan B, Gusev A, Trynka G, Reshef Y, Loh P-R, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47:1228\u201335.","journal-title":"Nat Genet"},{"key":"2076_CR119","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ajhg.2018.03.021","volume":"102","author":"G Ni","year":"2018","unstructured":"Ni G, Moser G, Ripke S, Neale BM, Corvin A, Walters JTR, et al. Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood. Am J Hum Genet. 2018;102:1185\u201394.","journal-title":"Am J Hum Genet"},{"key":"2076_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18534-1","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, et al. Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture. Nat Commun. 2020;11:4799.","journal-title":"Nat Commun"},{"key":"2076_CR121","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41588-018-0193-x","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Qi G, Park J-H, Chatterjee N. Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits. Nat Genet. 2018;50:1318\u201326.","journal-title":"Nat Genet"},{"key":"2076_CR122","doi-asserted-by":"publisher","first-page":"eaap8757","DOI":"10.1126\/science.aap8757","volume":"360","author":"V Anttila","year":"2018","unstructured":"THE BRAINSTORM CONSORTIUM, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, et al. Analysis of shared heritability in common disorders of the brain. Science. 2018;360:eaap8757.","journal-title":"Science."},{"key":"2076_CR123","doi-asserted-by":"publisher","first-page":"fcac125","DOI":"10.1093\/braincomms\/fcac125","volume":"4","author":"V Escott-Price","year":"2022","unstructured":"Escott-Price V, Hardy J. Genome-wide association studies for Alzheimer\u2019s disease: bigger is not always better. Brain Commun. 2022;4:fcac125.","journal-title":"Brain Commun"},{"key":"2076_CR124","doi-asserted-by":"publisher","unstructured":"Grotzinger AD, Fuente J, Priv\u00e9 F, Nivard MG, Tucker-Drob EM. Pervasive downward bias in estimates of liability-scale heritability in GWAS Meta-Analysis: A Simple Solution. Biol Psychiatry. 2022. https:\/\/doi.org\/10.1016\/j.biopsych.2022.05.029.","DOI":"10.1016\/j.biopsych.2022.05.029"},{"key":"2076_CR125","doi-asserted-by":"publisher","unstructured":"Robette N, G\u00e9nin E, Clerget-Darpoux F. Heritability: what\u2019s the point? What is it not for? A human genetics perspective. Genetica. 2022. https:\/\/doi.org\/10.1007\/s10709-022-00149-7.","DOI":"10.1007\/s10709-022-00149-7"},{"key":"2076_CR126","doi-asserted-by":"publisher","first-page":"iyaa046","DOI":"10.1093\/genetics\/iyaa046","volume":"217","author":"D Holland","year":"2021","unstructured":"Holland D, Frei O, Desikan R, Fan C-C, Shadrin AA, Smeland OB, et al. The genetic architecture of human complex phenotypes is modulated by linkage disequilibrium and heterozygosity. Genetics. 2021;217:iyaa046.","journal-title":"Genetics."},{"key":"2076_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08992-7","volume":"10","author":"M Levy-Sakin","year":"2019","unstructured":"Levy-Sakin M, Pastor S, Mostovoy Y, Li L, Leung AKY, McCaffrey J, et al. Genome maps across 26 human populations reveal population-specific patterns of structural variation. Nat Commun. 2019;10:1025.","journal-title":"Nat Commun"},{"key":"2076_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1828-7","volume":"20","author":"M Mahmoud","year":"2019","unstructured":"Mahmoud M, Gobet N, Cruz-D\u00e1valos DI, Mounier N, Dessimoz C, Sedlazeck FJ. Structural variant calling: the long and the short of it. Genome Biol. 2019;20:246.","journal-title":"Genome Biol"},{"key":"2076_CR129","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins RL, Brand H, Karczewski KJ, Zhao X, Alf\u00f6ldi J, Francioli LC, et al. A structural variation reference for medical and population genetics. Nature. 2020;581:444\u201351.","journal-title":"Nature."},{"key":"2076_CR130","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302:841.","journal-title":"Science."},{"key":"2076_CR131","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ng1718","volume":"38","author":"A Rovelet-Lecrux","year":"2006","unstructured":"Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerri\u00e8re A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38:24\u201326.","journal-title":"Nat Genet"},{"key":"2076_CR132","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/mp.2016.226","volume":"22","author":"K Le Guennec","year":"2017","unstructured":"Le Guennec K, Quenez O, Nicolas G, Wallon D, Rousseau S, Richard A-C, et al. 17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression. Mol Psychiatry. 2017;22:1119\u201325.","journal-title":"Mol Psychiatry"},{"key":"2076_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.119","volume":"2","author":"Y Li","year":"2012","unstructured":"Li Y, Shaw CA, Sheffer I, Sule N, Powell SZ, Dawson B, et al. Integrated copy number and gene expression analysis detects a CREB1 association with Alzheimer\u2019s disease. Transl Psychiatry. 2012;2:e192.","journal-title":"Transl Psychiatry"},{"key":"2076_CR134","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-2010-1212","volume":"19","author":"EL Heinzen","year":"2010","unstructured":"Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, Strittmatter WJ, et al. Genome-wide scan of copy number variation in late-onset Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2010;19:69\u201377.","journal-title":"J Alzheimers Dis JAD"},{"key":"2076_CR135","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2174\/156720512802455331","volume":"9","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Shen L, Kim S, Inlow M, West JD, Faber KM, et al. Analysis of copy number variation in Alzheimer\u2019s disease: the NIALOAD\/ NCRAD Family Study. Curr Alzheimer Res. 2012;9:801\u201314.","journal-title":"Curr Alzheimer Res"},{"key":"2076_CR136","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/hmg\/dds476","volume":"22","author":"J Chapman","year":"2013","unstructured":"Chapman J, Rees E, Harold D, Ivanov D, Gerrish A, Sims R, et al. A genome-wide study shows a limited contribution of rare copy number variants to Alzheimer\u2019s disease risk. Hum Mol Genet. 2013;22:816\u201324.","journal-title":"Hum Mol Genet"},{"key":"2076_CR137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/JAD-160469","volume":"55","author":"D Cuccaro","year":"2017","unstructured":"Cuccaro D, De Marco EV, Cittadella R, Cavallaro S. Copy number variants in Alzheimer\u2019s disease. J Alzheimers Dis JAD. 2017;55:37\u201352.","journal-title":"J Alzheimers Dis JAD"},{"key":"2076_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1856-3","volume":"20","author":"A De Roeck","year":"2019","unstructured":"De Roeck A, De Coster W, Bossaerts L, Cacace R, De Pooter T, Van, et al. NanoSatellite: accurate characterization of expanded tandem repeat length and sequence through whole genome long-read sequencing on PromethION. Genome Biol. 2019;20:239.","journal-title":"Genome Biol"},{"key":"2076_CR139","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tig.2021.06.015","volume":"38","author":"EJ Hollox","year":"2022","unstructured":"Hollox EJ, Zuccherato LW, Tucci S. Genome structural variation in human evolution. Trends Genet TIG. 2022;38:45\u201358.","journal-title":"Trends Genet TIG"},{"key":"2076_CR140","doi-asserted-by":"publisher","first-page":"188.e3","DOI":"10.1016\/j.neurobiolaging.2018.08.001","volume":"72","author":"ES Gusareva","year":"2018","unstructured":"Gusareva ES, Twizere J-C, Sleegers K, Dourlen P, Abisambra JF, Meier S, et al. Male-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer\u2019s disease. Neurobiol Aging. 2018;72:188.e3\u2013188.e12.","journal-title":"Neurobiol Aging"},{"key":"2076_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-3368-2","volume":"21","author":"Y-C Chang","year":"2020","unstructured":"Chang Y-C, Wu J-T, Hong M-Y, Tung Y-A, Hsieh P-H, Yee SW, et al. GenEpi: gene-based epistasis discovery using machine learning. BMC Bioinforma. 2020;21:68.","journal-title":"BMC Bioinforma"},{"key":"2076_CR142","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajhg.2018.01.015","volume":"102","author":"YJ Sung","year":"2018","unstructured":"Sung YJ, Winkler TW, de Las Fuentes L, Bentley AR, Brown MR, Kraja AT, et al. A large-scale multi-ancestry genome-wide study accounting for smoking behavior identifies multiple significant loci for blood pressure. Am J Hum Genet. 2018;102:375\u2013400.","journal-title":"Am J Hum Genet"},{"key":"2076_CR143","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s42003-022-03287-y","volume":"5","author":"C Sarnowski","year":"2022","unstructured":"Sarnowski C, Ghanbari M, Bis JC, Logue M, Fornage M, Mishra A, et al. Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels. Commun Biol. 2022;5:336.","journal-title":"Commun Biol"},{"key":"2076_CR144","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/alz.12333","volume":"17","author":"V Damotte","year":"2021","unstructured":"Damotte V, van der Lee SJ, Chouraki V, Grenier-Boley B, Simino J, Adams H, et al. Plasma amyloid \u03b2 levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: a genome-wide association study in over 12,000 non-demented participants. Alzheimers Dement J Alzheimers Assoc. 2021;17:1663\u201374.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR145","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13195-021-00854-z","volume":"13","author":"H-R Kim","year":"2021","unstructured":"Kim H-R, Jung S-H, Kim J, Jang H, Kang SH, Hwangbo S, et al. Identifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population. Alzheimers Res Ther. 2021;13:117.","journal-title":"Alzheimers Res Ther"},{"key":"2076_CR146","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41593-021-00826-4","volume":"24","author":"SM Smith","year":"2021","unstructured":"Smith SM, Douaud G, Chen W, Hanayik T, Alfaro-Almagro F, Sharp K, et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat Neurosci. 2021;24:737\u201345.","journal-title":"Nat Neurosci"},{"key":"2076_CR147","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1212\/WNL.0000000000002909","volume":"87","author":"JM Farfel","year":"2016","unstructured":"Farfel JM, Yu L, Buchman AS, Schneider JA, De Jager PL, Bennett DA. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology. 2016;87:489\u201396.","journal-title":"Neurology."},{"key":"2076_CR148","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2021.05.014","volume":"107","author":"J Young","year":"2021","unstructured":"Young J, Gallagher E, Koska K, Guetta-Baranes T, Morgan K, Thomas A, et al. Genome-wide association findings from the brains for dementia research cohort. Neurobiol Aging. 2021;107:159\u201367.","journal-title":"Neurobiol Aging"},{"key":"2076_CR149","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87:539\u201347.","journal-title":"Neurology."},{"key":"2076_CR150","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772\u201381.","journal-title":"JAMA."},{"key":"2076_CR151","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 2021;141:709\u201324.","journal-title":"Acta Neuropathol"},{"key":"2076_CR152","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1474-4422(14)70065-1","volume":"13","author":"R Ferrari","year":"2014","unstructured":"Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JBJ, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol. 2014;13:686\u201399.","journal-title":"Lancet Neurol"},{"key":"2076_CR153","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1212\/WNL.0b013e31820a0e3b","volume":"76","author":"N Finch","year":"2011","unstructured":"Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011;76:467\u201374.","journal-title":"Neurology."},{"key":"2076_CR154","first-page":"706","volume":"144","author":"SO Tom\u00e9","year":"2021","unstructured":"Tom\u00e9 SO, Thal DR. Co-pathologies in Alzheimer\u2019s disease: just multiple pathologies or partners in crime? Brain. J Neurol. 2021;144:706\u20138.","journal-title":"J Neurol"},{"key":"2076_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-018-1861-8","volume":"136","author":"DH Paushter","year":"2018","unstructured":"Paushter DH, Du H, Feng T, Hu F. The lysosomal function of progranulin, a guardian against neurodegeneration. Acta Neuropathol. 2018;136:1\u201317.","journal-title":"Acta Neuropathol"},{"key":"2076_CR156","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-020-02246-3","volume":"141","author":"T Feng","year":"2021","unstructured":"Feng T, Lacrampe A, Hu F. Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders. Acta Neuropathol. 2021;141:327\u201339.","journal-title":"Acta Neuropathol"},{"key":"2076_CR157","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nm.3672","volume":"20","author":"SS Minami","year":"2014","unstructured":"Minami SS, Min S-W, Krabbe G, Wang C, Zhou Y, Asgarov R, et al. Progranulin protects against amyloid \u03b2 deposition and toxicity in Alzheimer\u2019s disease mouse models. Nat Med. 2014;20:1157\u201364.","journal-title":"Nat Med"},{"key":"2076_CR158","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"SM Purcell","year":"2009","unstructured":"International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher PM, O\u2019Donovan MC, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748\u201352.","journal-title":"Nature"},{"key":"2076_CR159","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41588-018-0279-5","volume":"51","author":"D Speed","year":"2019","unstructured":"Speed D, Balding DJ. SumHer better estimates the SNP heritability of complex traits from summary statistics. Nat Genet. 2019;51:277\u201384.","journal-title":"Nat Genet"},{"key":"2076_CR160","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajhg.2015.09.001","volume":"97","author":"BJ Vilhj\u00e1lmsson","year":"2015","unstructured":"Vilhj\u00e1lmsson BJ, Yang J, Finucane HK, Gusev A, Lindstr\u00f6m S, Ripke S, et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am J Hum Genet. 2015;97:576\u201392.","journal-title":"Am J Hum Genet"},{"key":"2076_CR161","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12653-0","volume":"10","author":"LR Lloyd-Jones","year":"2019","unstructured":"Lloyd-Jones LR, Zeng J, Sidorenko J, Yengo L, Moser G, Kemper KE, et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat Commun. 2019;10:5086.","journal-title":"Nat Commun"},{"key":"2076_CR162","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","volume":"15","author":"SW Choi","year":"2020","unstructured":"Choi SW, Mak TS-H, O\u2019Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15:2759\u201372.","journal-title":"Nat Protoc"},{"key":"2076_CR163","doi-asserted-by":"publisher","first-page":"e1003348","DOI":"10.1371\/journal.pgen.1003348","volume":"9","author":"F Dudbridge","year":"2013","unstructured":"Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013;9:e1003348.","journal-title":"PLoS Genet"},{"key":"2076_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09718-5","volume":"10","author":"T Ge","year":"2019","unstructured":"Ge T, Chen C-Y, Ni Y, Feng Y-CA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019;10:1776.","journal-title":"Nat Commun"},{"key":"2076_CR165","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1093\/brain\/awv268","volume":"138","author":"V Escott-Price","year":"2015","unstructured":"Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, et al. Common polygenic variation enhances risk prediction for Alzheimer\u2019s disease. Brain J Neurol. 2015;138:3673\u201384.","journal-title":"Brain J Neurol"},{"key":"2076_CR166","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1093\/cercor\/bhr348","volume":"22","author":"MR Sabuncu","year":"2012","unstructured":"Sabuncu MR, Buckner RL, Smoller JW, Lee PH, Fischl B, Sperling RA, et al. The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex. 2012;22:2653\u201361.","journal-title":"Cereb Cortex"},{"key":"2076_CR167","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1212\/WNL.0000000000002922","volume":"87","author":"EC Mormino","year":"2016","unstructured":"Mormino EC, Sperling RA, Holmes AJ, Buckner RL, De Jager PL, Smoller JW, et al. Polygenic risk of Alzheimer disease is associated with early- and late-life processes. Neurology. 2016;87:481\u20138.","journal-title":"Neurology."},{"key":"2076_CR168","first-page":"2167","volume":"141","author":"MA Scelsi","year":"2018","unstructured":"Scelsi MA, Khan RR, Lorenzi M, Christopher L, Greicius MD, Schott JM, et al. Genetic study of multimodal imaging Alzheimer\u2019s disease progression score implicates novel loci. Brain. J Neurol. 2018;141:2167\u201380.","journal-title":"J Neurol"},{"key":"2076_CR169","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ana.24999","volume":"82","author":"V Escott-Price","year":"2017","unstructured":"Escott-Price V, Myers AJ, Huentelman M, Hardy J. Polygenic risk score analysis of pathologically confirmed Alzheimer disease. Ann Neurol. 2017;82:311\u20134.","journal-title":"Ann Neurol"},{"key":"2076_CR170","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/mp.2016.18","volume":"22","author":"A Lacour","year":"2017","unstructured":"Lacour A, Espinosa A, Louwersheimer E, Heilmann S, Hern\u00e1ndez I, Wolfsgruber S, et al. Genome-wide significant risk factors for Alzheimer\u2019s disease: role in progression to dementia due to Alzheimer\u2019s disease among subjects with mild cognitive impairment. Mol Psychiatry. 2017;22:153\u201360.","journal-title":"Mol Psychiatry"},{"key":"2076_CR171","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jalz.2016.01.006","volume":"12","author":"E Louwersheimer","year":"2016","unstructured":"Louwersheimer E, Wolfsgruber S, Espinosa A, Lacour A, Heilmann-Heimbach S, Alegret M, et al. Alzheimer\u2019s disease risk variants modulate endophenotypes in mild cognitive impairment. Alzheimers Dement J Alzheimers Assoc. 2016;12:872\u201381.","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"2076_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-220025","volume":"89","author":"K Clark","year":"2022","unstructured":"Clark K, Leung YY, Lee W-P, Voight B, Wang L-S. Polygenic risk scores in Alzheimer\u2019s disease genetics: methodology, applications, inclusion, and diversity. J Alzheimers Dis JAD. 2022;89:1\u201312.","journal-title":"J Alzheimers Dis JAD"},{"key":"2076_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24082-z","volume":"12","author":"G Leonenko","year":"2021","unstructured":"Leonenko G, Baker E, Stevenson-Hoare J, Sierksma A, Fiers M, Williams J, et al. Identifying individuals with high risk of Alzheimer\u2019s disease using polygenic risk scores. Nat Commun. 2021;12:4506.","journal-title":"Nat Commun"},{"key":"2076_CR174","doi-asserted-by":"publisher","first-page":"104953","DOI":"10.1016\/j.nbd.2020.104953","volume":"142","author":"E Bellou","year":"2020","unstructured":"Bellou E, Stevenson-Hoare J, Escott-Price V. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol Dis. 2020;142:104953.","journal-title":"Neurobiol Dis"},{"key":"2076_CR175","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/1389202918666170307161450","volume":"18","author":"AJ Mayhew","year":"2017","unstructured":"Mayhew AJ, Meyre D. Assessing the heritability of complex traits in humans: methodological challenges and opportunities. Curr Genom. 2017;18:332\u201340.","journal-title":"Curr Genom"},{"key":"2076_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.","journal-title":"Genome Med"},{"key":"2076_CR177","first-page":"e10411","volume":"4","author":"TV Nguyen","year":"2020","unstructured":"Nguyen TV, Eisman JA. Post-GWAS polygenic risk score: utility and challenges. JBMR. 2020;4:e10411.","journal-title":"JBMR"},{"key":"2076_CR178","doi-asserted-by":"publisher","first-page":"101.e1","DOI":"10.1016\/j.neurobiolaging.2020.09.014","volume":"99","author":"B Fulton-Howard","year":"2021","unstructured":"Fulton-Howard B, Goate AM, Adelson RP, Koppel J, Gordon ML. Alzheimer\u2019s Disease Genetics Consortium, et al. Greater effect of polygenic risk score for Alzheimer\u2019s disease among younger cases who are apolipoprotein E-\u03b54 carriers. Neurobiol Aging. 2021;99:101.e1\u2013101.e9.","journal-title":"Neurobiol Aging"},{"key":"2076_CR179","doi-asserted-by":"publisher","first-page":"fcz047","DOI":"10.1093\/braincomms\/fcz047","volume":"2","author":"A Altmann","year":"2020","unstructured":"Altmann A, Scelsi MA, Shoai M, de Silva E, Aksman LM, Cash DM, et al. A comprehensive analysis of methods for assessing polygenic burden on Alzheimer\u2019s disease pathology and risk beyond APOE. Brain Commun. 2020;2:fcz047.","journal-title":"Brain Commun"},{"key":"2076_CR180","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-022-05275-y","volume":"610","author":"L Yengo","year":"2022","unstructured":"Yengo L, Vedantam S, Marouli E, Sidorenko J, Bartell E, Sakaue S, et al. A saturated map of common genetic variants associated with human height. Nature. 2022;610:704\u201312.","journal-title":"Nature."},{"key":"2076_CR181","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312\u201339.","journal-title":"Cell."},{"key":"2076_CR182","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, et al. Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol. 2017;133:839\u201356.","journal-title":"Acta Neuropathol"},{"key":"2076_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04362-x","volume":"9","author":"G Davies","year":"2018","unstructured":"Davies G, Lam M, Harris SE, Trampush JW, Luciano M, Hill WD, et al. Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nat Commun. 2018;9:2098.","journal-title":"Nat Commun"},{"key":"2076_CR184","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/d41573-022-00120-3","volume":"21","author":"D Ochoa","year":"2022","unstructured":"Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Disco. 2022;21:551.","journal-title":"Nat Rev Drug Disco"},{"key":"2076_CR185","doi-asserted-by":"publisher","first-page":"e12110","DOI":"10.1002\/trc2.12110","volume":"6","author":"AL Oblak","year":"2020","unstructured":"Oblak AL, Forner S, Territo PR, Sasner M, Carter GW, Howell GR, et al. Model organism development and evaluation for late-onset Alzheimer\u2019s disease: MODEL-AD. Alzheimers Dement N.Y. 2020;6:e12110.","journal-title":"Alzheimers Dement N.Y."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02076-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:33:28Z","timestamp":1698712408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02076-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":185,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2076"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02076-1","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}